The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID
Mental Health Clinician · 2026-06 · 16 (3) · 125-128
DOI: 10.9740/mhc.2026.06.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mental Health Clinician, 2026-06. Verfasst von Sara L Pucci und 3 weiteren Autor:innen. Beteiligte Einrichtung: (Corresponding author) Clinical Pharmacy Practitioner, VA Northeast Ohio Healthcare System, Cleveland, Ohio, sara.pucci@va.gov. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- (Corresponding author) Clinical Pharmacy Practitioner, VA Northeast Ohio Healthcare System, Cleveland, Ohio, sara.pucci@va.gov.
- Clinical Pharmacy Practitioner, VA Northeast Ohio Healthcare System, Cleveland, Ohio.
- PGY-2 Psychiatry Pharmacy Resident, VA Northeast Ohio Healthcare System, Cleveland, Ohio.
ORCID-Profile: Sara L Pucci, Allison Veide, Haley Pierce, Dana Kaminski
Zitieren
APA
Pucci, S. L., Veide, A., Pierce, H., & Kaminski, D. (2026). The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID. Mental Health Clinician, 16(3), 125-128. https://doi.org/10.9740/mhc.2026.06.125
Vancouver
Pucci SL, Veide A, Pierce H, Kaminski D. The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID. Mental Health Clinician. 2026;16(3):125-128. doi:10.9740/mhc.2026.06.125
BibTeX
@article{Pucci2026,
author = {Pucci, Sara L and Veide, Allison and Pierce, Haley and Kaminski, Dana},
title = {The expanding potential of low-dose naltrexone in clinical practice with a focus on long COVID},
journal = {Mental Health Clinician},
year = {2026},
volume = {16},
number = {3},
pages = {125--128},
doi = {10.9740/mhc.2026.06.125}
}
EUVIMED